|
|
Genomic Health® develops oncogenomic services that enhance the management of cancer. The first testing service — Oncotype DX® Breast Cancer Assay — is now available for use in clinical practice to quantify the likelihood of breast cancer recurrence and predict benefit from chemotherapy for an individual patient
|